Slørdahl Tobias S - Institutt for kreftforskning og molekylærmedisin, Norges teknisk-naturvitenskapelige universitet

基本信息

浏览量：43

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 76 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone

Tobias S Slørdahl,Frida Bugge Askeland, Margrete Sofie Sætre Hanssen, Håkon Hov, Stine Marie Sundt-Hansen, Sofia Lindahl,Nils Tore Vethe,Henrik Hjorth-Hansen,Mona H Fenstad,Anders Waage,Øyvind Hjertner,Fredrik Schjesvold,Anders Sundan

EJHaemno. 1 (2025): e1091-e1091

引用0浏览0WOS引用

Isatuximab, Bortezomib, Lenalidomide, and Limited Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma (REST): a Multicentre, Single-Arm, Phase 2 Trial

Frida Bugge Askeland,Einar Haukås,Tobias S Slørdahl,Anja Klostergaard, Tatjana Alexandersen,Anna Lysén,Pegah Abdollahi,Lene Kongsgaard Nielsen,Emil Hermansen,Fredrik Schjesvold

The Lancet Haematologyno. 2 (2025): e120-e127

引用0浏览0WOS引用

P-349 Multiple Myeloma Patients Who Are in VGPR or Better Benefits from Continued Treatment with Zoledronic Acid Beyond Two Years

Thomas Lund,Michael Tveden Gundesen,Annette Juul Vangsted,Carsten Helleberg,Einar Haukas,Trine Silkjaer,Jon Thor Asmussen,Elena Manuela Teodorescu,Bo Amdi Jensen,Tobias Slordahl,Hareth Nahi,Anders Waage,Niels Abildgaard,Fredrik Schjesvold

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S234-S235

引用0浏览0引用

Incidence and Prevention of Skeletal‐related Events in Multiple Myeloma Patients: A Population‐based Real‐world Experience

Marie Rora, Margrete Skretting Solberg,Kari Lenita Falck Moore,Tobias S. Slordahl

EJHAEMno. 4 (2024): 669-676

引用0浏览0WOS引用

VRD Versus VCD As Induction Therapy Before Autologous Stem Cell Transplantation in Multiple Myeloma: a Nationwide Population-Based Study

Jakob Nordberg Norgaard,Kari Lenita Falck Moore,Tobias S. Slordahl,Anders Vik,Tor Henrik Anderson Tvedt,Fredrik Schjesvold

Blood cancer journal（2024）

引用0浏览0WOSNATURE引用

P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW

Michael Gundesen,Fredrik Schjesvold,Annette Vangsted,Carsten Helleberg,Einar Haukås,Trine Silkjær, Elena Todorescu,Bo Amdi Jensen,Tobias S. Slørdahl,Jon Thor Asmussen,Hareth Nahi,Anders Waage,Niels Abildgaard,Thomas Lund

HemaSphereno. S3 (2023)

引用0浏览0引用

Supplementary Figure 3 from Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3

Pegah Abdollahi,Esten N. Vandsemb,Magnus A. Hjort,Kristine Misund,Toril Holien,Anne-Marit Sponaas,Torstein B. Rø,Tobias S. Slørdahl,Magne Børset

openalex（2023）

引用0浏览0引用

Will Survival Improve by Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study

Frida Bugge Askeland,Anne-Marie Rasmussen,Anna Lysen,Einar Haukas, Anette Loken Eilertsen, Magnus Moksnes,Galina Tsykunova,Anders Vik, Birgitte Dahl Eiken, Vidar Stavseth,Jurgen Rolke,Eivind Ottersen Samstad,Valdas Peceliunas,Randi Fykse Hallstensen, Ariane Aasbo Hansen, Anita Smith Nilsen,Tobias S. Slordahl,Fredrik Schjesvold

Clinical Lymphoma Myeloma & Leukemia (2023): S79-S80

引用0浏览0引用

A Patient with Minimal Myeloma Treatment Who Survived for 20 Years

Alenka Djarmila Behsen,Esten Nymoen Vandsemb,Tobias Schmidt Slordahl,Henrik Hjorth-Hansen,Petter Quist-Paulsen,Kristine Misund,Anne-Marit Sponaas,Anders Waage

Haematologica (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn